It is a long path from the development of an active pharmaceutical ingredient in the lab to an effective drug – a process that takes several years. Campus companies are often involved in this process on behalf of the pharmaceutical and biotech industry or academic groups.
The company Experimental Pharmacology & Oncology Berlin-Buch (EPO) is a leader in preclinical cancer research in Germany. Worldwide, EPO offers customized and comprehensive service for the preclinical development of novel cancer drugs and is specialized in the development of individualized tumor models.
Reorganization in the Executive Board of Eckert & Ziegler
The Supervisory Board of Eckert & Ziegler AG has now formally approved the reorganization of the Executive Board already announced in December 2022. Accordingly, the founder and Chairman of the Execut...more ...
Recognized Australian Endocrine & Hypertension Center Joins International Groups with a Clinical Trial of PentixaPharm’s Primary Aldosteronism Lead Candidate
Following clinical investigations of hypertension specialists in the Netherlands, France, the United States, and China, the Monash Medical Center (Monash Health) and Hudson Institute in Melbourne, Aus...more ...
Interview about Berlin-Buch – A Location for Future Innovation
The BerlinBioCube incubator is currently being built on Campus Berlin-Buch. The new five-story building provides a total of 8,000 m² of space for state-of-the-art laboratories, offices, and shared spa...more ...
realtime PCR und digital PCR Kurs
Lange Nacht der Wissenschaften 2023
Der Campus Berlin-Buch präsentiert sich mit Laborführungen, Experimenten zum Mitmachen, Vorträgen und vielem mehrmore ...
WEITERBILDUNGSTAG LABOR 4.0 FÜR TECHNISCHE ANGESTELLTE UND LABORANT*INNEN
Vorträge, Workshops, Networking, Methodentraining, Laborführungen rund um die Themen Digitalisierung, Automatisierung und Miniaturisierung in den Life Sciencesmore ...